Biological Mechanism(s) Underpinning the Association between Antipsychotic Drugs and Weight Gain

被引:9
作者
Panizzutti, Bruna [1 ]
Bortolasci, Chiara C. [1 ]
Spolding, Briana [1 ]
Kidnapillai, Srisaiyini [1 ]
Connor, Timothy [1 ]
Richardson, Mark F. [2 ]
Truong, Trang T. T. [1 ]
Liu, Zoe S. J. [1 ]
Gray, Laura [1 ,3 ]
Kim, Jee Hyun [1 ,3 ]
Dean, Olivia M. [1 ,3 ]
Berk, Michael [1 ,3 ,4 ,5 ]
Walder, Ken [1 ,6 ]
机构
[1] Deakin Univ, Sch Med, Inst Innovat Phys & Mental Hlth & Clin Translat, IMPACT, Geelong, Vic 3220, Australia
[2] Deakin Univ, Sch Life & Environm Sci, Genom Ctr, Geelong, Vic 3220, Australia
[3] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia
[4] Univ Melbourne, Royal Melbourne Hosp, Dept Psychiat, Parkville, Vic 3052, Australia
[5] Univ Melbourne, Ctr Youth Mental Hlth, Parkville, Vic 3052, Australia
[6] Orygen Youth Hlth Res Ctr, Parkville, Vic 3052, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
antipsychotics; weight gain; schizophrenia; lipid metabolism; bipolar disorder; metabolic syndrome; psychiatry; neuroscience; mental disorders; GENE POLYMORPHISMS; METABOLIC SYNDROME; SCHIZOPHRENIA; EXPRESSION;
D O I
10.3390/jcm10184095
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Weight gain and consequent metabolic alterations are common side-effects of many antipsychotic drugs. Interestingly, several studies have suggested that improvement in symptoms and adverse metabolic effects are correlated. We used next generation sequencing data from NT-2 (human neuronal) cells treated with aripiprazole, amisulpride, risperidone, quetiapine, clozapine, or vehicle control, and compared with the Pillinger P-score (ranked from 0 to 1, indicating greater increase in weight gain and related metabolic parameters) to identify the genes most associated with the drugs' propensity to cause weight gain. The top 500 genes ranked for their correlation with the drugs' propensity to cause weight gain were subjected to pathway analysis using DAVID (NIH). We further investigated transcription factors (TFs) that are more likely to regulate the genes involved in these processes using the prediction tool of key TFs from TRRUST. The results suggest an enrichment for genes involved in lipid biosynthesis and metabolism, which are of interest for mechanisms underpinning weight-gain. The list of genes involved in the lipid pathways that correlated with weight gain was enriched for genes transcriptionally regulated by SREBF1 and SREBF2. Furthermore, quetiapine significantly increased the expression of SREBF1 and SREBF2 in NT-2 cells. Our results suggest that the effects of these antipsychotic drugs on lipid metabolism may be mediated, at least in part, via regulation of SREBF1/SREBF2 expression, with evidence of a direct effect of quetiapine on the expression of SREBF1/2. The effects of antipsychotic drugs on lipid metabolism may influence white matter structure (therapeutic effect) and the risk of weight gain, lipid disturbances, and, consequently, metabolic syndrome (adverse effects). Understanding the different molecular effects of these drugs could inform a personalized medicine approach in treating patients with schizophrenia.
引用
收藏
页数:8
相关论文
共 41 条
  • [1] [Anonymous], R LANGUAGE ENV STAT
  • [2] Antipsychotics result in more weight gain in antipsychotic naive patients than in patients after antipsychotic switch and weight gain is irrespective of psychiatric diagnosis: A meta-analysis
    Bak, Maarten
    Drukker, Marjan
    Cortenraad, Shauna
    Vandenberk, Emma
    Guloksuz, Sinan
    [J]. PLOS ONE, 2021, 16 (02):
  • [3] Pharmacological management of atypical antipsychotic-induced weight gain
    Baptista, Trino
    ElFakih, Yamily
    Uzcategui, Euderruh
    Sandia, Ignacio
    Talamo, Eduardo
    de Baptista, Enma Araujo
    Beaulieu, Serge
    [J]. CNS DRUGS, 2008, 22 (06) : 477 - 495
  • [4] Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia
    Bartzokis, George
    Lu, Po H.
    Nuechterlein, Keith H.
    Gitlin, Michael
    Doi, Clarissa
    Edwards, Nancy
    Lieu, Christopher
    Altshuler, Lori L.
    Mintz, Jim
    [J]. SCHIZOPHRENIA RESEARCH, 2007, 93 (1-3) : 13 - 22
  • [5] CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING
    BENJAMINI, Y
    HOCHBERG, Y
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) : 289 - 300
  • [6] Targeting the microbiome-gut-brain axis for improving cognition in schizophrenia and major mood disorders: A narrative review
    Bioque, Miquel
    Gonzalez-Rodriguez, Alexandre
    Garcia-Rizo, Clemente
    Cobo, Jesus
    Antonio Monreal, Jose
    Usall, Judith
    Soria, Virginia
    Labad, Javier
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2021, 105
  • [7] Trimmomatic: a flexible trimmer for Illumina sequence data
    Bolger, Anthony M.
    Lohse, Marc
    Usadel, Bjoern
    [J]. BIOINFORMATICS, 2014, 30 (15) : 2114 - 2120
  • [8] Dietary Consumption Among Youth with Antipsychotic-Induced Weight Gain and Changes Following Healthy Lifestyle Education
    Bussell, Kristin
    Reeves, Gloria
    Hager, Erin
    Zhu, Shijun
    Correll, Christoph U.
    Riddle, Mark A.
    Sikich, Linmarie
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2021, 31 (05) : 364 - 375
  • [9] Overexpression of Insig-2 inhibits atypical antipsychotic-induced adipogenic differentiation and lipid biosynthesis in adipose-derived stem cells
    Chen, Chien-Chih
    Hsu, Li-Wen
    Huang, Kuang-Tzu
    Goto, Shigeru
    Chen, Chao-Long
    Nakano, Toshiaki
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [10] Therapeutic Response Is Associated With Antipsychotic-Induced Weight Gain in Drug-Naive First-Episode Patients With Schizophrenia: An 8-Week Prospective Study
    Chen, Ying Qi
    Li, Xi Rong
    Zhang, Lie
    Zhu, Wei Bo
    Wu, Ya Qing
    Guan, Xiao Ni
    Xiu, Mei Hong
    Zhang, Xiang Yang
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2021, 82 (03)